Garthwaite T L, Martinson D R, Tseng L F, Hagen T C, Menahan L A
Endocrinology. 1980 Sep;107(3):671-6. doi: 10.1210/endo-107-3-671.
Obese mice (C57BL/6J ob/ob) and their lean littermates were studied at various ages from immediately post weaning until 62 weeks of age, at which mortality increased markedly. Several age-related changes were noted. 1) Plasma glucose levels were elevated in obese mice 5-20 weeks and 62 weeks of age, but were similar to those in the lean mice at 20-60 weeks of age. Plasma insulin levels were elevated in obese mice, and there were no age-related differences. 2) Brain serotonin was elevated in obese mice at all ages and increased with age in both obese and lean animals. 3) Pituitary contents of ACTH and beta-endorphin were elevated in young obese mice and increased further as these mice approached their life expectancy. 4) The ratios of ACTH to beta-endorphin immunoreactivities were similar in obese and lean mice, except in obese mice over 50 weeks of age where this ratio was increased. We conclude that: 1) the obese mouse is characterized by hyperinsulinemia and hyperadrenocorticism throughout its life; 2) the insulin resistance of the obese mouse improves at 20 weeks of age, yet deteriorates as its life expectancy is approached; 3) the obese mouse has an elevated brain serotonin content similar to previously described elevations of the putative neurotransmitters dopamine and norepinephrine in these mice; and 4) as the obese mouse approaches its life expectancy, abnormalities may occur in the synthesis, processing, or secretion of ACTH and/or beta-endorphine.
对肥胖小鼠(C57BL/6J ob/ob)及其瘦的同窝小鼠从刚断奶后直至62周龄的不同年龄段进行了研究,62周龄时死亡率显著增加。观察到了一些与年龄相关的变化。1)肥胖小鼠在5 - 20周龄和62周龄时血浆葡萄糖水平升高,但在20 - 60周龄时与瘦小鼠相似。肥胖小鼠的血浆胰岛素水平升高,且不存在与年龄相关的差异。2)肥胖小鼠在所有年龄段脑血清素均升高,且在肥胖和瘦小鼠中均随年龄增加。3)幼龄肥胖小鼠垂体促肾上腺皮质激素(ACTH)和β-内啡肽含量升高,随着这些小鼠接近预期寿命,含量进一步增加。4)肥胖和瘦小鼠中ACTH与β-内啡肽免疫反应性的比值相似,但50周龄以上的肥胖小鼠该比值增加。我们得出结论:1)肥胖小鼠终生具有高胰岛素血症和肾上腺皮质功能亢进的特征;2)肥胖小鼠的胰岛素抵抗在20周龄时改善,但随着接近预期寿命而恶化;3)肥胖小鼠脑血清素含量升高,类似于先前描述的这些小鼠中假定神经递质多巴胺和去甲肾上腺素的升高;4)随着肥胖小鼠接近预期寿命,ACTH和/或β-内啡肽的合成、加工或分泌可能出现异常。